Cancer Therapy Advisor Staff

Researchers are conducting a phase 1 trial of multiple maintenance regimens in patients with extensive-stage small-cell lung cancer.

Researchers are conducting a phase 2 trial of the WEE1 inhibitor AZD1775 in combination with carboplatin and paclitaxel for patients with advanced/metastatic squamous cell lung cancer.

Patients in the first arm will undergo single booster vaccination, and patients in the second arm will undergo full revaccination.